Krystal Biotech (KRYS) Change in Account Payables (2016 - 2026)
Krystal Biotech recorded quarterly Change in Account Payables of $1.0 million in Q1 2026, up 658.47% quarter-over-quarter from -$183000.0 in Q4 2025, and up 12.8% year-over-year from $906000.0 in Q1 2025.
Krystal Biotech's Change in Account Payables history runs 11 years deep, the most recent figure standing at $1.0 million for Q1 2026.
- In Q1 2026, Change in Account Payables rose 12.8% year-over-year to $1.0 million; the TTM figure through Mar 2026 stood at $942000.0 (down 20.84% YoY), while the FY2025 annual figure was $826000.0, down 18.3% from the prior year.
- Change in Account Payables came in at $1.0 million for Q1 2026 at Krystal Biotech, up from -$183000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $4.1 million in Q2 2025 to a low of -$4.0 million in Q3 2025.
- A 5-year average of $88470.6 and a median of $91000.0 in 2024 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables surged 579.44% in 2024 and tumbled 4517.58% in 2025, its largest moves.
- Krystal Biotech's Change in Account Payables stood at -$938000.0 in 2022, then soared by 76.33% to -$222000.0 in 2023, then plunged by 166.22% to -$591000.0 in 2024, then jumped by 69.04% to -$183000.0 in 2025, then jumped by 658.47% to $1.0 million in 2026.
- According to Business Quant data, Change in Account Payables over the past three periods registered $1.0 million, -$183000.0, and -$4.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Krystal Biotech | 9.05 Bn | 8.23 Bn | 110.03 Mn | 1.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.02 Mn |
| Mar 31, 2026 | 1.02 Mn |
| Dec 31, 2025 | -183,000.00 |
| Dec 31, 2025 | -183,000.00 |
| Sep 30, 2025 | -4.02 Mn |
| Sep 30, 2025 | -4.02 Mn |
| Jun 30, 2025 | 4.12 Mn |
| Jun 30, 2025 | 4.12 Mn |
| Mar 31, 2025 | 906,000.00 |
| Mar 31, 2025 | 906,000.00 |
| Dec 31, 2024 | -591,000.00 |
| Dec 31, 2024 | -591,000.00 |
| Sep 30, 2024 | 91,000.00 |
| Sep 30, 2024 | 91,000.00 |
| Jun 30, 2024 | 784,000.00 |
| Jun 30, 2024 | 784,000.00 |
| Mar 31, 2024 | 727,000.00 |
| Mar 31, 2024 | 727,000.00 |
| Dec 31, 2023 | -222,000.00 |
| Dec 31, 2023 | -222,000.00 |
| Sep 30, 2023 | -360,000.00 |
| Sep 30, 2023 | -360,000.00 |
| Jun 30, 2023 | 374,000.00 |
| Jun 30, 2023 | 374,000.00 |
| Mar 31, 2023 | 107,000.00 |
| Mar 31, 2023 | 107,000.00 |
| Dec 31, 2022 | -938,000.00 |
| Dec 31, 2022 | -938,000.00 |
| Sep 30, 2022 | -340,000.00 |
| Sep 30, 2022 | -340,000.00 |
| Jun 30, 2022 | 578,000.00 |
| Jun 30, 2022 | 578,000.00 |
| Mar 31, 2022 | -554,000.00 |
| Mar 31, 2022 | -554,000.00 |
| Dec 31, 2021 | 937,000.00 |
| Dec 31, 2021 | 937,000.00 |
| Sep 30, 2021 | 455,000.00 |
| Sep 30, 2021 | 455,000.00 |
| Jun 30, 2021 | -974,000.00 |
| Jun 30, 2021 | -974,000.00 |
| Mar 31, 2021 | 294,000.00 |
| Mar 31, 2021 | 294,000.00 |
| Dec 31, 2020 | 58,000.00 |
| Dec 31, 2020 | 58,000.00 |
| Sep 30, 2020 | 19,000.00 |
| Sep 30, 2020 | 19,000.00 |
| Jun 30, 2020 | 462,000.00 |
| Jun 30, 2020 | 462,000.00 |
| Mar 31, 2020 | 244,000.00 |
| Mar 31, 2020 | 244,000.00 |
| Dec 31, 2019 | -369,000.00 |
| Dec 31, 2019 | -369,000.00 |
| Sep 30, 2019 | -243,000.00 |
| Sep 30, 2019 | -243,000.00 |
| Jun 30, 2019 | -170,000.00 |
| Jun 30, 2019 | -170,000.00 |
| Mar 31, 2019 | 583,000.00 |
| Mar 31, 2019 | 583,000.00 |
| Dec 31, 2018 | -17,000.00 |
| Dec 31, 2018 | -17,000.00 |
| Sep 30, 2018 | 108,000.00 |
| Sep 30, 2018 | 108,000.00 |
| Jun 30, 2018 | 125,000.00 |
| Jun 30, 2018 | 125,000.00 |
| Mar 31, 2018 | -104,000.00 |
| Mar 31, 2018 | -104,000.00 |
| Dec 31, 2017 | -138,000.00 |
| Dec 31, 2017 | -138,000.00 |
| Sep 30, 2017 | 90,000.00 |
| Sep 30, 2017 | 90,000.00 |
| Jun 30, 2017 | 165,000.00 |
| Jun 30, 2017 | 165,000.00 |
| Mar 31, 2017 | 16,000.00 |
| Mar 31, 2017 | 16,000.00 |
| Dec 31, 2016 | -20,000.00 |
| Dec 31, 2016 | -20,000.00 |